Skip to content
10-Q

Quarterly Report

Immune Design Corp.

0001437786-18-000037

← back to feed
Filed
May 3, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Apr 30, 2018 48.13M sh
Capex Q1 2018 · Mar 31, 2018 $204K
Capex Q1 2018 · Mar 31, 2017 $202K
Operating Cash Flow Q1 2018 · Mar 31, 2018 −$16.38M
Operating Cash Flow Q1 2018 · Mar 31, 2017 −$11.18M
Short Term Investments Q1 2018 · Mar 31, 2018 $58.71M
Short Term Investments Q1 2018 · Dec 31, 2017 $68.65M
Cash And Equivalents Q1 2018 · Mar 31, 2018 $72.17M
Cash And Equivalents Q1 2018 · Dec 31, 2017 $72.45M
Cash And Equivalents Q1 2018 · Mar 31, 2017 $27.92M
Stockholders Equity Q1 2018 · Mar 31, 2018 $128.86M
Stockholders Equity Q1 2018 · Dec 31, 2017 $139.21M
Current Liabilities Q1 2018 · Mar 31, 2018 $6.35M
Current Liabilities Q1 2018 · Dec 31, 2017 $14.52M
Current Assets Q1 2018 · Mar 31, 2018 $134.5M
Current Assets Q1 2018 · Dec 31, 2017 $153.14M
Total Assets Q1 2018 · Mar 31, 2018 $135.31M
Total Assets Q1 2018 · Dec 31, 2017 $153.83M
Sga Expense Q1 2018 · Mar 31, 2018 $4M
Sga Expense Q1 2018 · Mar 31, 2017 $4.14M
Rd Expense Q1 2018 · Mar 31, 2018 $10.31M
Rd Expense Q1 2018 · Mar 31, 2017 $14.04M
Net Income Q1 2018 · Mar 31, 2018 −$13.3M
Net Income Q1 2018 · Mar 31, 2017 −$12.62M
Operating Income Q1 2018 · Mar 31, 2018 −$13.81M
Operating Income Q1 2018 · Mar 31, 2017 −$12.75M
Revenue Q1 2018 · Mar 31, 2018 $503K
Revenue Q1 2018 · Mar 31, 2017 $5.47M